Platelet inhibitors for TIAS: A review of prospective drug trial results: Postgraduate Medicine: Vol 75, No 5

Views

CrossRef citations to date

Altmetric

Preview

Many studies have been done to assess the efficacy of platelet inhibitors, particularly aspirin, in the prevention of recurrent transient ischemic attacks and ultimately stroke. Dr Ramirez-Lassepas reviews the results of 19 prospective trials and concludes that we are still a long way from a definitive answer.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Platelet inhibitors for TIAS

A review of prospective drug trial results

Information for

Open access

Opportunities

Help and information

Platelet inhibitors for TIAS

A review of prospective drug trial results

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature